SCHEMBL10047609

SCHEMBL10047609

C=C(C)N/C(C)=N\N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23097741 0.73
SCHEMBL17656186 0.73
SCHEMBL13636125 0.72
SCHEMBL23348516 0.69 NOS3 (0.30)
SCHEMBL1887913 0.69
SCHEMBL12351640 0.69
SCHEMBL5924356 0.65
SCHEMBL15427690 0.65
SCHEMBL21199994 0.65
SCHEMBL21615393 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019018583-A1 1,8-NAPHTHYRIDINONE COMPOUNDS AND USES THEREOF GiraFpharma LLC (US) 2019-01-24 WO disclosed
US-20140200215-A1 LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS INTERMUNE, INC. 2014-07-17 US disclosed
EP-2148874-B1 PYRIMIDINE DERIVATIVES AND COMPOSITIONS AS C-KIT AND PDGFR KINASE INHIBITORS IRM LLC (BM) 2012-02-08 EP disclosed